AAB
AZN icon

ABN AMRO Bank’s AstraZeneca AZN Stock Holding History

ABN AMRO Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297M Sell
1,592,396
-852,775
-35% -$160M 3.84% 5
2026
Q1 		$482M Buy
2,445,171
+2,441,414
+64,983% +$471M 5.2% 3
2025
Q4 		$688K Sell
3,757
-325
-8% -$57K 0.01% 178
2025
Q3 		$624K Buy
+4,082
New +$618K 0.01% 192

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ABN AMRO Bank's AZN Position: Q2 2026 in Review

ABN AMRO Bank reduced its AstraZeneca (AZN) stake by 35% in Q2 2026, selling an estimated $160M and leaving 1,592,396 shares worth $297M. The position accounts for 3.84% of the portfolio, ranked #5.

ABN AMRO Bank first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $482M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • ABN AMRO Bank held 1,592,396 shares of AstraZeneca worth $297M as of Q2 2026.
  • ABN AMRO Bank sold 852,775 AstraZeneca shares in Q2 2026, an estimated $160M.
  • AstraZeneca made up 3.84% of ABN AMRO Bank's portfolio in Q2 2026, its #5 holding.
  • ABN AMRO Bank first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • ABN AMRO Bank's AstraZeneca position peaked at $482M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.